The China Medical Board (CMB) is an independent American foundation that aims to advance health in China and neighboring Asian countries through strengthening medical, nursing and public health research and education. CMB was started in 1914 as the second major program of the Rockefeller Foundation and endowed in 1928 as an independent foundation incorporated in New York. Its initial commitment was to establish and operate the Peking Union Medical College in Beijing which it carried out from 1914 through 1950. Since 1980, CMB has expanded support in medical education and research to more than a dozen medical universities in China and another dozen medical universities in Southeast Asia. In 2008, under the leadership of Dr. Lincoln Chen, CMB launched of a fresh initiative to strengthen scientific excellence in “critical capacities” among Chinese and Asian institutions to address the premier health challenges of the 21st century—equitable access to primary and preventive health services in market-driven economies. With this backdrop, under the encouragement of CMB senior staff, the China Health Policy and Management Society (CHPAMS) was created to facilitate scholarly exchange between health policy and systems sciences communities within and outside of China.
Dr. Chen was the Harvard School of Public Health Taro Takemi Professor of International Health, Director of the University-wide Harvard Center for Population and Development Studies, and the founding Director of the Harvard Global Equity Initiative. Earlier, Dr. Chen served as Executive Vice-President of the Rockefeller Foundation, and he represented the Ford Foundation in India and Bangladesh.